Growth Metrics

Sarepta Therapeutics (SRPT) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn -6.75%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.75%
Dec 31, 2025 1.41%
Sep 30, 2025 17.38%
Jun 30, 2025 34.63%
Mar 31, 2025 44.64%
Dec 31, 2024 49.83%
Sep 30, 2024 43.99%
Jun 30, 2024 46.24%
Mar 31, 2024 36.33%
Dec 31, 2023 26.17%
Sep 30, 2023 17.33%
Jun 30, 2023 3.05%
Mar 31, 2023 -2.34%
Dec 31, 2022 -5.82%
Sep 30, 2022 -9.16%
Jun 30, 2022 -9.85%
Mar 31, 2022 -7.81%
Dec 31, 2021 0.38%
Sep 30, 2021 16.03%
Jun 30, 2021 32.60%
Mar 31, 2021 47.90%
Dec 31, 2020 46.91%
Sep 30, 2020 43.66%
Jun 30, 2020 30.84%
Mar 31, 2020 29.21%
Dec 31, 2019 33.60%
Sep 30, 2019 55.56%
Jun 30, 2019 103.39%
Mar 31, 2019 97.08%
Dec 31, 2018 124.82%
Sep 30, 2018 97.68%
Jun 30, 2018 46.28%
Mar 31, 2018 40.39%
Dec 31, 2017 14.17%
Sep 30, 2017 9.13%
Jun 30, 2017 8.95%
Mar 31, 2017 3.87%
Dec 31, 2016 1.22%
Sep 30, 2016 -4.71%
Jun 30, 2016 -2.79%
Mar 31, 2016 -2.06%
Dec 31, 2015 -3.01%
Sep 30, 2015 0.54%
Jun 30, 2015 84.48%
Mar 31, 2015 87.58%
Dec 31, 2014 155.84%
Sep 30, 2014 350.97%
Jun 30, 2014 500.27%
Mar 31, 2014 551.88%
Dec 31, 2013 343.01%
Mar 31, 2013 -24.77%
Dec 31, 2012 -20.35%
Dec 31, 2011 106.04%